Efficacy and predictors of virological non‐suppression in Thailand's rollout of dolutegravir‐based first‐line antiretroviral therapy: A nationwide cohort analysis is a research paper published in HIV Medicine (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: U01 AI069907
NHLBI NIH HHS
National Institute on Alcohol Abuse and Alcoholism
U.S. National Institute of Health's (NIH) National Institute of Allergy and Infectious Diseases
TREAT Asia/amfAR, The Foundation for AIDS Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute on Drug Abuse
Fogarty International Center
National Institute of Mental Health
FIC NIH HHS
NCI NIH HHS
NIMH NIH HHS
Eunice Kennedy Shriver National Institute of Child Health and Human Development
NIAAA NIH HHS
NIDA NIH HHS
NIDDK NIH HHS
National Cancer Institute
National Heart, Lung, and Blood Institute
amfAR, The Foundation for AIDS Research
NHLBI NIH HHS
NIAAA NIH HHS
NIMH NIH HHS
U.S. National Institute of Health's (NIH) National Institute of Allergy and Infectious Diseases
NIDDK NIH HHS
NIDA NIH HHS
FIC NIH HHS
TREAT Asia/amfAR, The Foundation for AIDS Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
NCI NIH HHS
NCI NIH HHS
NIMH NIH HHS
NIDA NIH HHS
NHLBI NIH HHS
NIAAA NIH HHS
NIDDK NIH HHS
FIC NIH HHS
FWCI
0.00
Citation Percentile
0.4%
Fields of Study
MeSH Terms
Keywords